Dr. Hu brings diverse experience in corporate finance, strategy, and business development across the life sciences industry. Most recently, Dr. Hu was acting Chief Business Officer of Yarra Therapeutics, a clinical-stage rare disease company. Previously, Dr. Hu was Senior Vice President, Business Development at Dimension Therapeutics, where he was a leader of teams that successfully brought the company through an IPO, several strategic partnering transactions, and ultimately an acquisition by Ultragenyx. Previously, he was Senior Director, Business Development at Cubist Pharmaceuticals. Dr. Hu also previously worked as part of the investment banking team at Leerink Partners, where he was part of teams which successfully executed over $600 million in equity financings for public and private life sciences companies, and as a senior consultant at Strategic Decisions Group, where he led strategic consulting engagements for several of the world’s largest biopharma companies.
Dr. Hu received his AB in Environmental Science and Public Policy from Harvard University, an M.D. from Baylor College of Medicine, and a MBA from the Jones Graduate School of Management at Rice University.